The Anti-inflammatory and Antifibrosis Effects of Anthocyanin Extracted From Black Soybean on a Peyronie Disease Rat Model

Objective To evaluate the potential of anthocyanin as a supplement for the treatment of Peyronie disease (PD) by examining the anti-inflammatory and antifibrosis activities of anthocyanin in a PD animal model. Materials and Methods We performed the preliminary experiment to confirm the plaque format...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2014-11, Vol.84 (5), p.1112-1116
Hauptverfasser: Sohn, Dong Wan, Bae, Woong Jin, Kim, Hyo Sin, Kim, Sun Wook, Kim, Sae Woong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To evaluate the potential of anthocyanin as a supplement for the treatment of Peyronie disease (PD) by examining the anti-inflammatory and antifibrosis activities of anthocyanin in a PD animal model. Materials and Methods We performed the preliminary experiment to confirm the plaque formation of tunica albuginea (TA). Six animals received fibrin (TISSEEL VH Sealer; Baxter, Glendale, CA; 30 μL each of human fibrin and thrombin solutions) injections into the TA. After 2 weeks, PD-like plaque formation was confirmed by Masson trichrome staining in preliminary experimental animal group. A PD rat model was made by intratunical injection of fibrin. Experimental animals were divided into 3 groups as follows: control group (n = 8), PD group (n = 8), and anthocyanin-treated group (n = 8) that received anthocyanin at 50 mg/kg twice a day for 4 weeks using orogastric tubes. After 4 weeks, penile tissue was collected to perform Masson trichrome and transforming growth factor (TGF)-β1 staining. Results We confirmed PD-like plaque formation by Masson trichrome stain 2 weeks after fibrin injection. The ratio of smooth muscle cells in the corpus cavernosum in the PD group was significantly lower than that of the control group ( P  
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2014.06.026